MeSH term
Frequency | Condition_Probility | Family Health | 2 | 0.0 |
Female | 13 | 0.0 |
Genotype | 4 | 0.0 |
Humans | 27 | 0.0 |
Male | 11 | 0.0 |
Mutation | 5 | 0.0 |
Neural Tube Defects/*genetics | 2 | 5.0 |
Pedigree | 4 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Transcription Factors/*genetics | 7 | 0.0 |
Adult | 2 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Exons | 3 | 0.0 |
Holoprosencephaly/*genetics | 8 | 44.0 |
Homeodomain Proteins/*genetics | 3 | 0.0 |
Introns | 3 | 0.0 |
*Mutation | 4 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Pregnancy | 4 | 0.0 |
Repressor Proteins/*genetics | 2 | 0.0 |
Animals | 11 | 0.0 |
Mice | 7 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Models, Genetic | 2 | 0.0 |
Syndrome | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant, Newborn | 7 | 0.0 |
Karyotyping | 3 | 0.0 |
Middle Aged | 2 | 0.0 |
Base Sequence | 10 | 0.0 |
Holoprosencephaly/epidemiology/*genetics | 2 | 100.0 |
Infant | 3 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Trans-Activators/*genetics | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Zinc Fingers/*genetics | 2 | 1.0 |
Binding Sites | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
*Nerve Tissue Proteins | 2 | 0.0 |
*Repressor Proteins | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
*Xenopus Proteins | 2 | 0.0 |
Cell Line | 3 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Zinc Fingers | 4 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
Nerve Tissue Proteins/genetics | 2 | 0.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
Gene Targeting | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Child | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Down-Regulation | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
Drosophila | 2 | 0.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Chromosomes, Human, Pair 13/*genetics | 2 | 2.0 |
Dandy-Walker Syndrome/*genetics/pathology | 2 | 66.0 |
Fatal Outcome | 3 | 0.0 |
Holoprosencephaly/*genetics/pathology | 3 | 75.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |